Fundz

OncoCyte Corp

IRVINE, CA · Biotechnology, Genetics, Health Care · 56 employees

Oncocyte™ is a precision diagnostics company with a mission to improve patient outcomes by providing personalized insights that inform critical decisions throughout the patient care journey.

Funding history

  • Funding Round — $21.7M — Feb 2025
  • Funding Round — $10.2M — Oct 2024
  • Funding Round — $15.8M — Apr 2024
  • Series seed — $3.0M — Apr 2021
  • Funding Round — $5.0M — Mar 2021

Recent signals

  • May 13, 2026: SEC 8-K (2.02): On May 13, 2026, Insight Molecular Diagnostics Inc. announced its financial results for the three months ended March 31, 2026. The press release outlines the company's performance metrics, including revenues and earnings figures for the first quarter, providing insights into the company's operational effectiveness and market position. This event is significant as it informs shareholders and potential investors about the company’s financial health and future prospects, emphasizing transparency and adherence to regulatory standards. The details are included in the press release furnished as Exhibit 99.1.
  • Feb 10, 2026: SEC 8-K (1.01): On February 10, 2026, Insight Molecular Diagnostics Inc. entered into securities purchase agreements with institutional investors for a registered direct offering. The Company agreed to issue and sell 3,482,498 shares of its common stock at an offering price of $5.75 per share, and Pre-Funded Warrants to purchase up to 1,043,478 additional shares at a price of $5.7499 per warrant. This transaction is backed by an effective shelf registration statement and is expected to enhance the Company's capital for growth initiatives.
  • Feb 24, 2025: Raised $21.7M
  • Jan 06, 2025: Launched Oncocyte Corp. Launches VitaGraft™ Kidney to Enhance Monitoring of Kidney Transplant Patients
  • Oct 08, 2024: Raised $10.2M
  • Oct 02, 2024: Oncocyte Corporation Announces $10.2 Million Private Placement of Securities
  • Jun 17, 2024: Oncocyte Corporation Appoints Andrea James as Chief Financial Officer and Principal Financial Officer
  • Apr 25, 2024: Raised $15.8M

See plans & pricing → Track OncoCyte Corp’s funding, hiring, and signals — with verified contacts — on Fundz.